Adaptive Biotechnologies (ADPT) EPS (Diluted) (QoQ) (2021 - 2026)
Adaptive Biotechnologies (ADPT) EPS (Diluted) (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.78 Bn | 3.56 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -258.12% |
| Dec 31, 2025 | -262.68% |
| Sep 30, 2025 | 107.22% |
| Jun 30, 2025 | -304.06% |
| Mar 31, 2025 | 4.83% |
| Dec 31, 2024 | 3.14% |
| Sep 30, 2024 | 30.65% |
| Jun 30, 2024 | 5.19% |
| Mar 31, 2024 | 31.23% |
| Dec 31, 2023 | -38.34% |
| Sep 30, 2023 | -5.04% |
| Jun 30, 2023 | 17.65% |
| Mar 31, 2023 | -47.36% |
| Dec 31, 2022 | 20.17% |
| Sep 30, 2022 | 26.48% |
| Jun 30, 2022 | 68.43% |
| Mar 31, 2022 | -222.70% |
| Dec 31, 2021 | 76.56% |
| Sep 30, 2021 | 21.95% |
| Jun 30, 2021 | 9.01% |